Repligen (RGEN) Posts Q4 Loss of 1c/Share
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $166.66 -1.41%
Financial Fact:
(Loss) income from operations: 3.75M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
(Loss) income from operations: 3.75M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q4 EPS of ($0.01), $0.05 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $15.4 million versus the consensus estimate of $14.7 million.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Benchmark Reiterates Speculative Buy Rating on Nephros (NEPH) Following Strong Q2 Results
- Klarna Group plc (KLAR) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
